Universal Ibogaine Inc (TSX-V:IBO) has said its research and development clinic in Winnipeg, the Kelburn Mental Health and Addiction Recovery Centre, is scheduled to reopen and commence business operations on October 17, 2022.
In a statement, Dr Ian Rabb, Universal Ibogaine chief clinics officer, said: "Progress is going remarkably well on the renovations and program development, we have key hires in place, and we are excited to open and start helping people again. We are looking at about 50% of our expanded occupancy when we open the doors again in October as of today."
He added: "We have a large referral network for clients, and the situation with the addiction and opioid crisis is still only getting worse by the day so we will likely be full pretty quickly."
READ: Universal Ibogaine targets October re-opening of Kelburn addiction treatment facility near Winnipeg
“We are also quite pleased with the progress we are making on the ibogaine clinical trial process. We will be the first legal ibogaine clinic in Canada. This could be the turning point in the opioid crisis," Rabb concluded.
Universal Ibogaine is a life sciences company, with a mission to transform addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorder and ultimately to utilize that protocol globally through planned future licensing agreements.
The company is concurrently developing a state-of-the-art holistic addiction treatment protocol at its Kelburn Recovery Centre that, when paired with the planned ibogaine detox protocol, is intended to revolutionize the way addiction is treated, and drastically improve the lives of individuals and families affected by addiction.
Contact the author at jon.hopkins@proactiveinvestors.com